Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

Simona Sica, C. Martínez, C. Canals, B. Sarina, E. P. Alessandrino, D. Karakasis, A. Pulsoni, M. Trneny, J. A. Snowden, E. Kanfer, N. Milpied, A. Bosi, S. Guidi, C. A. De Souza, R. Willemze, R. Arranz, L. Jebavy, A. Hellmann, D. Sibon, R. OnetoJ. J. Luan, P. Dreger, L. Castagna, A. Sureda

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT.
Original languageEnglish
Pages (from-to)2430-2434
Number of pages5
JournalAnnals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume24
DOIs
Publication statusPublished - 2013

Keywords

  • Hodgkin's lymphoma
  • autologous stem cell transplantation
  • relapse

Fingerprint

Dive into the research topics of 'Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation'. Together they form a unique fingerprint.

Cite this